These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31451680)

  • 1. Expression of KIF18A Is Associated with Increased Tumor Stage and Cell Proliferation in Prostate Cancer.
    Zhang H; Shen T; Zhang Z; Li Y; Pan Z
    Med Sci Monit; 2019 Aug; 25():6418-6428. PubMed ID: 31451680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
    Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
    Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
    Zhang X; Wang Y; Ning Y
    Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIF18A knockdown reduces proliferation, migration, invasion and enhances radiosensitivity of esophageal cancer.
    Qian LX; Cao X; Du MY; Ma CX; Zhu HM; Peng Y; Hu XY; He X; Yin L
    Biochem Biophys Res Commun; 2021 Jun; 557():192-198. PubMed ID: 33872988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
    IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.
    Zhang Z; Xie H; Zhu S; Chen X; Yu J; Shen T; Li X; Shang Z; Niu Y
    Med Sci Monit; 2018 Nov; 24():8190-8197. PubMed ID: 30427826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of kinesin KIF18A in the invasion and metastasis of hepatocellular carcinoma.
    Luo W; Liao M; Liao Y; Chen X; Huang C; Fan J; Liao W
    World J Surg Oncol; 2018 Feb; 16(1):36. PubMed ID: 29466986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinesin 18A expression: clinical relevance to colorectal cancer progression.
    Nagahara M; Nishida N; Iwatsuki M; Ishimaru S; Mimori K; Tanaka F; Nakagawa T; Sato T; Sugihara K; Hoon DS; Mori M
    Int J Cancer; 2011 Dec; 129(11):2543-52. PubMed ID: 21213216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy.
    Zeng X; Hu Z; Wang Z; Tao J; Lu T; Yang C; Lee B; Ye Z
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):119-25. PubMed ID: 24418912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
    Cai J; Shen G; Liu S; Meng Q
    Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
    Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
    Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARHGAP29 expression may be a novel prognostic factor of cell proliferation and invasion in prostate cancer.
    Shimizu K; Matsumoto H; Hirata H; Ueno K; Samoto M; Mori J; Fujii N; Kawai Y; Inoue R; Yamamoto Y; Yano S; Shimabukuro T; Furutani-Seiki M; Matsuyama H
    Oncol Rep; 2020 Dec; 44(6):2735-2745. PubMed ID: 33125156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinesin Family Member 18A (KIF18A) Contributes to the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells In Vitro and In Vivo.
    Chen FT; Zhong FK
    Dis Markers; 2019; 2019():6383685. PubMed ID: 31772692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
    Ji J; Shen T; Li Y; Liu Y; Shang Z; Niu Y
    Oncol Rep; 2021 Mar; 45(3):921-932. PubMed ID: 33650660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo.
    Yu F; Lin Y; Xu X; Liu W; Tang D; Zhou X; Wang G; Zheng Y; Xie A
    Int J Oncol; 2020 Jul; 57(1):139-150. PubMed ID: 32319597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
    BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W; Liu Y; Chen H; Ning H; Ding K
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer.
    Cui F; Hu J; Ning S; Tan J; Tang H
    Prostate; 2018 Dec; 78(16):1299-1310. PubMed ID: 30095171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Silencing of ezrin gene inhibits proliferation and invasion of human prostate cancer PC-3 cells].
    Yang N; Wang L; Chen X; Liu J; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):821-4. PubMed ID: 27371852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
    Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.